Arlington Heights, IL, Aug. 08, 2017 -- The American Society of Plastic Surgeons (ASPS) is proud to welcome Sientra, a leading medical aesthetics company, as a Platinum Level sponsor of Plastic Surgery The Meeting, which takes place October 6 – 10 in Orlando. The premier educational and networking event for board-certified plastic surgeons across the world, Plastic Surgery The Meeting is attended by more than 3,000 plastic surgeons, trainees and other allied health professionals interested in translating the continuing medical education and information they receive into their practices to improve patient care and outcomes.
|
|||
"Sientra has a long-standing commitment to patient safety, product quality and technological innovation,” said Debra Johnson, MD, president of the American Society of Plastic Surgeons. “We value their commitment to working exclusively with board-certified plastic surgeons and appreciate their continued support of the patient safety and enhanced quality-of-life outcomes we advance at Plastic Surgery The Meeting.”
Corporate partners at the Premier Support levels receive unprecedented opportunities to communicate with aesthetic and reconstructive plastic surgeons from around the world. The Platinum Level of support is intended for companies who want to stand apart from their competitors by demonstrating the highest level of commitment to the education of plastic surgeons and advancement of the specialty.
“We are excited to continue our long-standing partnership with ASPS, a society that shares our commitment to the specialty of board-certified plastic surgeons,” said Sientra Chairman and Chief Executive Officer, Jeff Nugent. “As we continue to build a diversified global aesthetics company, we appreciate the opportunities the partnership affords us and is increasingly important in building relationships with key aesthetic and reconstructive plastic surgeons.”
For more information, visit our Plastic Surgery The Meeting website.
About Sientra
Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company committed to making a difference in patients’ lives by enhancing their body image, growing their self-esteem and restoring their confidence. The Company was founded to provide greater choice to board-certified plastic surgeons and patients in need of medical aesthetics products. The Company has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company sells its breast implants and breast tissue expanders exclusively to board-certified and board-admissible plastic surgeons and tailors its customer service offerings to their specific needs. The Company also offers a range of other aesthetic and specialty products including BIOCORNEUM®, the professional choice in scar management, and miraDry, the only FDA cleared device to reduce underarm sweat, odor and permanently reduce hair of all colors.
For more information about Sientra, visit www.sientra.com
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/0db87659-6991-4653-87a7-8fbf4b9ea857
Adam Ross American Society of Plastic Surgeons 773-332-4719 [email protected]


U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 



